Clough Capital Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-42,800
| Closed | -$9.92M | – | 135 |
|
|
2024
Q2 | $9.92M | Buy |
+42,800
| New | +$9.92M | 1.08% | 37 |
|
|
2019
Q1 | – | Sell |
-11,485
| Closed | -$3.46M | – | 132 |
|
|
2018
Q4 | $3.46M | Buy |
11,485
+2,288
| +25% | +$688K | 0.41% | 70 |
|
|
2018
Q3 | $3.25M | Sell |
9,197
-875
| -9% | -$309K | 0.31% | 70 |
|
|
2018
Q2 | $2.92M | Sell |
10,072
-2,485
| -20% | -$721K | 0.26% | 74 |
|
|
2018
Q1 | $3.44M | Sell |
12,557
-15,160
| -55% | -$4.15M | 0.33% | 71 |
|
|
2017
Q4 | $8.83M | Sell |
27,717
-24,955
| -47% | -$7.95M | 0.74% | 50 |
|
|
2017
Q3 | $16.5M | Sell |
52,672
-550
| -1% | -$172K | 1.11% | 30 |
|
|
2017
Q2 | $14.4M | Sell |
53,222
-3,122
| -6% | -$847K | 1% | 29 |
|
|
2017
Q1 | $15.4M | Sell |
56,344
-6,635
| -11% | -$1.81M | 0.98% | 30 |
|
|
2016
Q4 | $17.9M | Buy |
62,979
+19,049
| +43% | +$5.4M | 1.18% | 28 |
|
|
2016
Q3 | $13.8M | Buy |
+43,930
| New | +$13.8M | 0.72% | 50 |
|
|
2015
Q3 | – | Sell |
-78,386
| Closed | -$31.7M | – | 199 |
|
|
2015
Q2 | $31.7M | Buy |
+78,386
| New | +$31.7M | 1.21% | 23 |
|
|
2014
Q4 | – | Sell |
-82,130
| Closed | -$27.2M | – | 178 |
|
|
2014
Q3 | $27.2M | Sell |
82,130
-1,200
| -1% | -$397K | 1.02% | 35 |
|
|
2014
Q2 | $26.3M | Buy |
83,330
+34,416
| +70% | +$10.9M | 0.83% | 40 |
|
|
2014
Q1 | $15M | Sell |
48,914
-23,742
| -33% | -$7.26M | 0.47% | 83 |
|
|
2013
Q4 | $20.3M | Sell |
72,656
-24,100
| -25% | -$6.74M | 0.67% | 55 |
|
|
2013
Q3 | $23.3M | Buy |
96,756
+59,300
| +158% | +$14.3M | 0.72% | 49 |
|
|
2013
Q2 | $8.06M | Buy |
+37,456
| New | +$8.06M | 0.27% | 120 |
|